• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The first clinical case due to AP92 like strain of CCHF

Shiloh

Editor, Senior Moderator
Source: http://7thspace.com/headlines/31163...morrhagic_fever_virus_and_a_field_survey.html

The first clinical case due to AP92 like strain of Crimean-CongoHemorrhagic Fever virus and a field survey


Crimean-Congo Hemorrhagic Fever (CCHF) is a fatal infection, but no clinical case due to AP92 strain was reported. We described the first clinical case due to AP92 like CCHFV.

Methods: A case infected by a AP92 like CCHFV was detected in Balkanian part of Turkey.

Diagnosis was confirmed by RT-PCR and sequencing. A human serologic and tick survey studies were performed in the region, where the case detected.

Results: Thirty eight individuals out of 741 were found to be anti CCHFV IgM positive.

The attack rate for overall CCHFV was calculated as 5.2%. In univariate analyses, CCHFV IgM positivity was found to be associated with the age (p<0.001), male gender (p=0.001), agricultural activity (p=0.036), and history of tick bite (p=0.014).

In multivariate analysis, older age (OR: 1.03, CI:1.01-1.05, p<0.001), male gender were found to be the risk factors (OR: 2.5, CI:1.15-5.63, p=0.020) for CCHFV infection.

Conclusions: This is the first human case with AP92 like CCHFV infection. Furthermore, this is the first report of AP92 like strain in Turkey.

In the region, elderly males carry the highest risk for CCHFV infection.

Author: Kenan MidilliAysen GargiliOnder ErgonulMurat ElevliSevgi ErginNesrin TuranGonul SengozRecep OzturkMehmet Bakar
Credits/Source: BMC Infectious Diseases 2009, 9:90
 
Back
Top